Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

marcainNovember 2 2015

A drug advisory for Marcain Polyamp Steripack 0.5% (bupivacaine hydrochloride) has been issued due to the administration advice included on labelling.

AstraZeneca has advised the MHRA that all batches issued since December 2012 are affected, with cartons and vial labels stating the product can be administered by intra-ocular administration. However, this route of administration is not appropriate for the 0.5% strength.

The ‘caution in use’ warning means that affected batches will continue to be distributed while the labelling is corrected, and that newly labelled stock is expected to be available from January 2016.

While the NHS Central Alerting System has indicated that it is unlikely that the product will be used in general practice or stocked by community pharmacies, the Scottish Executive Health Department has asked directors of pharmacy to bring the alert to the attention of community pharmacists and GPs.

Links:

MHRA announcement

SEHD advisory

NHS Central Alerting System statement

July 19 2018 The medicines regulator has issued a Drug Safety Update relating to suspected adverse drug reactions associated with medicines taken during pregnancy.
July 11 2018 New Medicines Service data indicates community pharmacists manage 19 out of 20 hypertensive patients without the need to refer a patient back to the GP. Analysis of 131,419 patient...